SPY330.30+3.33 1.02%
DIA272.81+1.37 0.50%
IXIC10,963.64+184.84 1.71%

Raymond James Reiterates Outperform on Mirum Pharmaceuticals, Lowers Price Target to $28

Raymond James reiterates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Outperform and lowers the price target from $30 to $28.

Benzinga · 05/08/2020 12:51

Raymond James reiterates Mirum Pharmaceuticals (NASDAQ:MIRM) with a Outperform and lowers the price target from $30 to $28.